Taylor Hoffman Wealth Management Abbott Laboratories Transaction History

Taylor Hoffman Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $30,620 - $37,011	-300 Reduced 11.86%	2,230 $246,000
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $4,621 - $5,658	-40 Reduced 1.56%	2,530 $356,000
Q3 2020 Oct 29, 2020	SELL	$91.64 - $111.29 $3,940 - $4,785	-43 Reduced 1.65%	2,570 $280,000
Q4 2018 Jul 11, 2019	SELL	$65.56 - $74.27 $26,224 - $29,708	-400 Reduced 13.28%	2,613 $189,000
Q1 2018 May 10, 2018	BUY	$56.27 - $63.62 $71,744 - $81,115	1,275 Added 73.36%	3,013 $180,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $90,611 - $97,009	1,688 Added 3376.0%	1,738 $99,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $2,684 - $2,873	50	50 $3,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Taylor Hoffman Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Taylor Hoffman Wealth Management with notifications on news.